Epigenetic Regulation of Cancer - Part D
- 1st Edition, Volume 390 - January 27, 2025
- Editors: Lorenzo Galluzzi, Sheila Spada
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 7 7 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 7 8 - 7
Epigenetic Regulation of Cancer, Part D, Volume 390 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume pr… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteEpigenetic Regulation of Cancer, Part D, Volume 390 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of hot topics, including Revisiting Epigenetic Regulation in Cancer: Evolving Trends and Translational Implications, Epigenetic Alteration in Cervical Cancer Induced by Human Papillomavirus, Integrative analysis of transcriptome, chromatin accessibility, cell surface antigen in single cell level for AML, Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity, and much more.
Other chapters cover The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer, Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance, and more.
Other chapters cover The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer, Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance, and more.
- Provides the latest information on cancer research
- Offers outstanding and original reviews on a range of cancer research topics
- Serves as an indispensable reference for researchers and students alike
International Research Community, Industry Professionals, Academic Institutions
1. Preface
Sheila Spada
2. Revisiting Epigenetic Regulation in Cancer: Evolving Trends and Translational Implications
Hifzur R. Siddique, Ranjan Kumar, Dhruv Mishra and Mohammad Afsar Khan
3. Epigenetic Alteration in Cervical Cancer Induced by Human Papillomavirus
Maria Elizbeth Alvarez Sánchez, Elisa Elvira Figueroa Angulo, Jonathan Puente Rivera, Yussel Fernando Perez Navarro and Edgar Mendieta Condado
4. Integrative analysis of transcriptome, chromatin accessibility, cell surface antigen in single cell level for AML
Christopher E. Mason
5. Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity
Jose Luis Garcia-Gimenez, Salvador Mena-Mollá, Irene Canovas-Cervera and Guillermo Suay-Montagud
6. The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer
Syed Musthapa Meeran, Priya Mondal and Gowthami Jayaprakash
7. Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance
Nageswaran Sivalingam and Sruthi Sritharan
Sheila Spada
2. Revisiting Epigenetic Regulation in Cancer: Evolving Trends and Translational Implications
Hifzur R. Siddique, Ranjan Kumar, Dhruv Mishra and Mohammad Afsar Khan
3. Epigenetic Alteration in Cervical Cancer Induced by Human Papillomavirus
Maria Elizbeth Alvarez Sánchez, Elisa Elvira Figueroa Angulo, Jonathan Puente Rivera, Yussel Fernando Perez Navarro and Edgar Mendieta Condado
4. Integrative analysis of transcriptome, chromatin accessibility, cell surface antigen in single cell level for AML
Christopher E. Mason
5. Role of miRNAs as epigenetic regulators of immune checkpoints in lung cancer immunity
Jose Luis Garcia-Gimenez, Salvador Mena-Mollá, Irene Canovas-Cervera and Guillermo Suay-Montagud
6. The translational potential of epigenetic modulatory bioactive phytochemicals as adjuvant therapy against cancer
Syed Musthapa Meeran, Priya Mondal and Gowthami Jayaprakash
7. Strategies for improving chemotherapeutic sensitivity and the epigenetic regulation of doxorubicin resistance
Nageswaran Sivalingam and Sruthi Sritharan
- No. of pages: 277
- Language: English
- Edition: 1
- Volume: 390
- Published: January 27, 2025
- Imprint: Academic Press
- Hardback ISBN: 9780443344770
- eBook ISBN: 9780443344787
LG
Lorenzo Galluzzi
Lorenzo Galluzzi is Assistant Professor of Cell Biology in Radiation Oncology at the Department of Radiation Oncology of the Weill Cornell Medical College, Honorary Assistant Professor Adjunct with the Department of Dermatology of the Yale School of Medicine, Honorary Associate Professor with the Faculty of Medicine of the University of Paris, and Faculty Member with the Graduate School of Biomedical Sciences and Biotechnology of the University of Ferrara, the Graduate School of Pharmacological Sciences of the University of Padova, and the Graduate School of Network Oncology and Precision Medicine of the University of Rome “La Sapienza”. Moreover, he is Associate Director of the European Academy for Tumor Immunology and Founding Member of the European Research Institute for Integrated Cellular Pathology.
Galluzzi is best known for major experimental and conceptual contributions to the fields of cell death, autophagy, tumor metabolism and tumor immunology. He has published over 450 articles in international peer-reviewed journals and is the Editor-in-Chief of four journals:
OncoImmunology (which he co-founded in 2011), International Review of Cell and Molecular Biology, Methods in Cell biology, and Molecular and Cellular Oncology (which he co-founded in 2013). Additionally, he serves as Founding Editor for Microbial Cell and Cell Stress, and Associate Editor for Cell Death and Disease, Pharmacological Research and iScience.
Affiliations and expertise
Assistant Professor of Cell Biology in Radiation Oncology, Department of Radiation Oncology, Weill Cornell Medical College, NY, USASS
Sheila Spada
Sheila Spada is at Weill Cornell Medical College, NY, USA
Affiliations and expertise
Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USARead Epigenetic Regulation of Cancer - Part D on ScienceDirect